Xiu B[au] - Search Results

Year	Number of Results
2000	1
2003	3
2005	1
2006	1
2009	2
2010	4
2011	7
2012	6
2013	6
2014	4
2015	7
2016	10
2017	4
2018	5
2019	13
2020	7
2021	7
2022	10
2023	6
2024	15
2025	11

1

Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response.

He X, Wang Q, Cheng X, Wang W, Li Y, Nan Y, Wu J, Xiu B, Jiang T, Bergholz JS, Gu H, Chen F, Fan G, Sun L, Xie S, Zou J, Lin S, Wei Y, Lee J, Asara JM, Zhang K, Cantley LC, Zhao JJ. He X, et al. Among authors: xiu b. Cell. 2025 Apr 3;188(7):1858-1877.e21. doi: 10.1016/j.cell.2025.01.043. Epub 2025 Feb 28. Cell. 2025. PMID: 40023152

2

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.

Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J, Guo R, Si J, Li L, Xue J, Shao ZM, Wu ZH, Huang S, Wu J. Xiu B, et al. Mol Cancer. 2019 Dec 19;18(1):187. doi: 10.1186/s12943-019-1115-y. Mol Cancer. 2019. PMID: 31856843 Free PMC article.

3

A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy.

Li Z, Chen S, Feng W, Luo Y, Lai H, Li Q, Xiu B, Li Y, Li Y, Huang S, Zhu X. Li Z, et al. Among authors: xiu b. EBioMedicine. 2020 Dec;62:103074. doi: 10.1016/j.ebiom.2020.103074. Epub 2020 Nov 9. EBioMedicine. 2020. PMID: 33161227 Free PMC article.

4

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

Zhang Q, Xiu B, Zhang L, Chen M, Chi W, Li L, Guo R, Xue J, Yang B, Huang X, Shao ZM, Huang S, Chi Y, Wu J. Zhang Q, et al. Among authors: xiu b. J Immunother Cancer. 2022 Oct;10(10):e004666. doi: 10.1136/jitc-2022-004666. J Immunother Cancer. 2022. PMID: 36252997 Free PMC article.

5

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

Zhang Q, Wang X, Shao Z, Zhang Y, Zhang L, Chen M, Zhou X, Zhu H, Zhou Y, Lu X, Li P, Chi W, Li L, Shao ZM, Huang S, Xue J, Chi Y, Wu J, Xiu B. Zhang Q, et al. Among authors: xiu b. Adv Sci (Weinh). 2025 Apr;12(14):e2413527. doi: 10.1002/advs.202413527. Epub 2025 Feb 14. Adv Sci (Weinh). 2025. PMID: 39950924 Free PMC article.

6

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

He M, Hao S, Ma L, Xiu B, Yang B, Wang Z, Xue J, Chi Y, Xiong M, Chen J, Huang X, Liu X, Wu S, Xiao Q, Huang Y, Shui R, Cao A, Li J, Di G, Yang W, Hu X, Liu G, Yu K, Jiang Y, Wang Z, Shao Z, Wu J. He M, et al. Among authors: xiu b. EClinicalMedicine. 2024 Jun 28;74:102700. doi: 10.1016/j.eclinm.2024.102700. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39045544 Free PMC article.

7

CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations.

Xue B, Liu Y, Zhou J, Zhou L, Ye S, Lu Y, Zhang W, Xiu B, Liang A, Li P, Lu Y, Qian W, Luo X. Xue B, et al. Among authors: xiu b. Cytotherapy. 2024 Dec;26(12):1465-1471. doi: 10.1016/j.jcyt.2024.07.011. Epub 2024 Jul 25. Cytotherapy. 2024. PMID: 39217529

8

CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration.

Zheng S, Yang B, Li L, Chen M, Zhang L, Chi W, Shao ZM, Xiu B, Chi Y, Wu J. Zheng S, et al. Among authors: xiu b. Int Immunopharmacol. 2024 Mar 10;129:111625. doi: 10.1016/j.intimp.2024.111625. Epub 2024 Feb 13. Int Immunopharmacol. 2024. PMID: 38354509

9

DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB.

Wang X, Chi W, Ma Y, Zhang Q, Xue J, Shao ZM, Xiu B, Wu J, Chi Y. Wang X, et al. Among authors: xiu b. Transl Oncol. 2024 Aug;46:102016. doi: 10.1016/j.tranon.2024.102016. Epub 2024 Jun 5. Transl Oncol. 2024. PMID: 38843658 Free PMC article.

10

CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma.

Liu Y, Xiao G, Liu Y, Tu S, Xue B, Zhong Y, Zhang C, Zhou L, Ye S, Lu Y, Xiu B, Zhang W, Ding Y, Fu J, Li P, Huang L, Luo X, Liang A. Liu Y, et al. Among authors: xiu b. Curr Res Transl Med. 2025 Jan-Mar;73(1):103477. doi: 10.1016/j.retram.2024.103477. Epub 2024 Oct 23. Curr Res Transl Med. 2025. PMID: 39481140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year